Tounjian Advisory Partners, LLC Merck & Co., Inc. Transaction History
Tounjian Advisory Partners, LLC
- $299 Billion
- Q3 2025
A detailed history of Tounjian Advisory Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tounjian Advisory Partners, LLC holds 12,262 shares of MRK stock, worth $1.14 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
12,262
Previous 22,698
45.98%
Holding current value
$1.14 Million
Previous $2.04 Billion
49.49%
% of portfolio
0.34%
Previous 0.39%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,878Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...